Robin Leigh Hand, CRNP
Adult Health · Charleston
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Robin Leigh Hand’s office at (843) 792-1414 to ask if they take your plan before you enroll.
Medicaid work
$7,495 in 2023
Medicaid paid $7,495 for 277 billed services this clinician did in 2023, up to 32 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug | 102 | $4,290 |
| Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour | 112 | $2,516 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure) | 49 | $433 |
| Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure) | 14 | $256 |
| 2023 | 277 | 4 | 32 | $7,495 |
| 2022 | 708 | 4 | 33 | $27,389 |
| 2021 | 295 | 4 | 27 | $48,381 |
| 2020 | 259 | 1 | 25 | $13,097 |
| 2019 | 258 | 2 | 27 | $9,794 |
| 2018 | 44 | 1 | 18 | $1,915 |
See the largest Medicaid services in earlier years
2022
| Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug | 349 | $19,068 |
| Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour | 256 | $6,865 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure) | 91 | $1,368 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 12 | $87 |
2021
| Infliximab not biosimil 10mg | 15 | $31,718 |
| Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug | 238 | $15,576 |
| Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour | 24 | $807 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure) | 18 | $280 |
2020
| Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug | 259 | $13,097 |
2019
| Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug | 237 | $9,608 |
| Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure) | 21 | $185 |
2018
| Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug | 44 | $1,915 |
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 167 Part D prescriptions in 2019.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2019 | 167 | 67 | 0% (0) | None | $24,514 |
| 2018 | 807 | 149 | 0% (0) | 7% | $138,293 |
| 2017 | 22 | 15 | 0% (0) | None | $6,309 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2019: 3 drugs
| Carbidopa-Levodopa | 65 | $3,757 | $58 |
| Carbidopa-Levodopa Er | 23 | $1,703 | $74 |
| Donepezil | 12 | $166 | $14 |
2018: 16 drugs
| Nuplazid | Parkinson's psychosis | 23 | $64,006 | $2,783 |
| Carbidopa-Levodopa | None | 259 | $14,587 | $56 |
| Rasagiline Mesylate | None | 14 | $6,979 | $498 |
| Amantadine | None | 48 | $6,350 | $132 |
| Entacapone | None | 17 | $6,265 | $369 |
| Carbidopa-Levodopa Er | None | 70 | $4,002 | $57 |
| Memantine | None | 17 | $1,591 | $94 |
| Mirtazapine | None | 31 | $1,250 | $40 |
| Pramipexole Dihydrochloride | None | 13 | $1,152 | $89 |
| Donepezil | None | 38 | $716 | $19 |
| Clonazepam | None | 65 | $688 | $11 |
| Gabapentin | None | 13 | $608 | $47 |
| Primidone | None | 13 | $291 | $22 |
| Propranolol | None | 16 | $240 | $15 |
| Sertraline | None | 22 | $181 | $8 |
| Quetiapine | None | 22 | $139 | $6 |
Money from drug and device companies
$32 in 2023
| 2023 | 2 | 2 | None | $32 |
| 2022 | 2 | 4 | None | $54 |
| 2021 | 1 | 1 | None | $17 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | Superion Indirect Decompression System | $18 | 1 payment
|
| Abbvie | Rinvoq | $14 | 1 payment
|
See all 2 published payments
| Abbvie | Meals · 2023-12-02 | Rinvoq | $14 |
| Boston Scientific | Meals · 2023-01-24 | Superion Indirect Decompression System | $18 |
See earlier years (2022, 2021)
2022: $54
| Boston Scientific | Spectra Wavewriter | $41 | 3 payments
|
| Abbvie | Humira | $13 | 1 payment
|
2021: $17
| Boston Scientific | Spectra Wavewriter | $17 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 73.8 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1659686475
- Licence
- AL 1-051106, SC 21177
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LA2200X (363LA2200X)
- Mailing address
- Po Box 751461, Charlotte, NC, 28275
- NPI first listed
- 2010-08-17
- NPI last updated
- 2022-07-21
This is when the NPI record was last certified, not a medical board exam.